SCHEMBL6911529

SCHEMBL6911529

CCCCCc1sc2ccccc2c1N

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 6/20 0.54
CNR1 P21554 3/20 0.54
PTPN1 P18031 4/20 0.50
LOXL2 Q9Y4K0 1/20 0.42
TLR8 Q9NR97 4/20 0.42
TLR7 Q9NYK1 1/20 0.42
IKBKB O14920 1/20 0.40
LIMK1 P53667 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
KMT2A Q03164 1/20 0.40
ATM Q13315 1/20 0.40
HSD17B10 Q99714 1/20 0.40
FAAH O00519 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6060597 0.81 CNR2 (0.52) CNR2CNR1PTPN1LOXL2KDM4E
SCHEMBL11205839 0.80 PTPN1 (0.57) CNR2CNR1PTPN1KDM4EALDH1A1
SCHEMBL31229334 0.80 CNR2 (0.51) CNR2CNR1PTPN1TLR8KDM4E
SCHEMBL11210513 0.80 LOXL2 (0.59) CNR2CNR1PTPN1LOXL2MEN1
SCHEMBL4429817 0.80 CNR2 (0.51) CNR2CNR1PTPN1LOXL2KDM4E
SCHEMBL10450091 0.80 CNR2 (0.51) CNR2CNR1PTPN1TLR8KDM4E
SCHEMBL28521552 0.79 CNR2 (0.50) CNR2CNR1PTPN1LOXL2MAPT
SCHEMBL28519218 0.79 CNR2 (0.50) CNR2CNR1PTPN1LOXL2MAPT
SCHEMBL1666933 0.76 SMN1; SMN2 (0.48) CNR2CNR1PTPN1IKBKBLIMK1
SCHEMBL7940185 0.76 CNR2 (0.50) CNR2CNR1PTPN1LOXL2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040044224-A1 Process for preparing 2-phenyl-3-aminobenzothiophenes CONRAD PRESTON CHARLES (US) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044224-A1 Process for preparing 2-phenyl-3-aminobenzothiophenes TPST2, SULT1A1, TYR CNR2 4619/4885CNR1 4658/4885PTPN1 2222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.